Allianz Asset Management
AMRX icon

Allianz Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Allianz Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+13,000
New +$178K ﹤0.01% 2079
2025
Q2 		– Sell
-38,900
Closed -$326K – 1997
2025
Q1 		$326K Buy
+38,900
New +$325K ﹤0.01% 2012
2019
Q2 		– Sell
-101,799
Closed -$1.44M – 2672
2019
Q1 		$1.44M Buy
+101,799
New +$1.35M ﹤0.01% 1959

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Allianz Asset Management's AMRX Position: Q2 2026 in Review

Allianz Asset Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 13,000 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #2079 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in AMRX as recently as Q1 2025.

Allianz Asset Management first reported a position in AMRX in Q1 2019 and has held it in 3 quarters since. The position peaked at $1.44M in Q1 2019. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Allianz Asset Management held 13,000 shares of Amneal Pharmaceuticals worth $225K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Allianz Asset Management position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #2079 holding.
  • Allianz Asset Management first reported a position in Amneal Pharmaceuticals in Q1 2019 and has held it in 3 quarters since.
  • Allianz Asset Management's Amneal Pharmaceuticals position peaked at $1.44M in Q1 2019.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.